Fraunhofer-Gesellschaft
Fraunhofer-Gesellschaft
Dr. Kai Sohn vom Fraunhofer IGB hat
© Fraunhofer / Simon Koy

Opening the Door to Practical Applications

Caught in time: Kai Sohn from Fraunhofer IGB and his team have developed a noninvasive method to diagnose dangerous pancreatic cancer at an early stage.

© Fraunhofer / Simon Koy

New solutions for medicine

Web special Fraunhofer magazine 3.2025

Artificial intelligence and innovative blood tests make it possible to detect cancer, sepsis and tuberculosis earlier and earlier. We can combat these effectively with new substances and personalized therapies. Fraunhofer researchers are now opening the door to the application of medical innovations.

 

© Fraunhofer Magazin / Simon Koy

“CAR T Cells Detect Tumors Throughout the Body.”

The therapy still costs up to 400,000 euros. But costs can be reduced by improved production methods. The new variant of CAR T immune cell therapy is now also targeting solid tumors. The modified immune cells can even track down metastases. This gives hope to many patients. Fraunhofer helps to put scientific excellence into practice.

more info
 

© Fraunhofer Magazin / Simon Koy

The Industrial Revolution for Cancer Therapy

Artificial intelligence instead of manual labor: Highly automated production aims to make CAR T-cell therapy affordable. An initial production platform already exists.

more info
 

© Fraunhofer Magazin / Simon Koy

The Eternal Battle against the White Plague

Tuberculosis is treatable. Despite this, over one million people die from this disease every year. This can be mitigated by new diagnostic tests and active substances. The danger is close at hand. The proportion of multidrug-resistant pathogens is especially high in Ukraine, among other countries.

more info
 

© Fraunhofer Magazin / Simon Koy

A Gentler Look at Tumors

Lower radiation exposure in the diagnosis and treatment of cancer: Fraunhofer researchers are drawing on a technology from a completely different field.

more info
 

© Fraunhofer IGD

Surviving Blood Poisoning

Sepsis is one of the most common causes of death worldwide. An early warning system employing AI-supported sensors can save lives. How Fraunhofer researchers want to enable the detection of health risks.

more info
 

© Fraunhofer Magazin / Simon Koy

The Next Level in Tumor Diagnostics

Fraunhofer researchers have developed a highly effective method for the early detection of pancreatic cancer. This approach could bring huge advances to precision medicine.

more info
 

Fraunhofer magazine
3/2025

Cover story: Open the Door! New solutions for medicine | and much more

Fraunhofer Group for Health

Healthcare research is one of the most multifaceted fields of innovation for the future. Intelligent innovations will have to make a significant contribution to affordable healthcare and to securing the future of society.

The Fraunhofer Health Group brings together the expertise and technologies of six institutes in the fields of medicine, pharmacy, medical technology, and biotechnology. 

The high degree of interdisciplinarity within the group across the four major topics − data, devices, diagnostics, and drugs − makes it possible to address forward-looking innovations and achieve recognizable added value for health research and patients.

Contact persons

Contact Press / Media

Prof. Dr. Dr. Gerd Geißlinger

Chairman Fraunhofer Group for Health

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Theodor-Stern-Kai 7
60596 Frankfurt am Main, Germany

Phone +49 69 6301-7620

Contact Press / Media

Dr. Otto Quintus Russe

Head of central office Fraunhofer Group for Health

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Sandhöfer Allee 1
60528 Frankfurt am Main, Germany

Phone +49 69 6301 84900